Reference
Kotake K, et al. Evaluation of Risk of Cardiac or Cerebrovascular Events in Romosozumab Users Focusing on Comorbidities: Analysis of the Japanese Adverse Drug Event Report Database. . Journal of Pharmacy Technology 39: 23-28, No. 1, Feb 2023. Available from: URL: http://doi.org/10.1177/87551225221144960
Rights and permissions
About this article
Cite this article
Hypertension increases risk of romosozumab cardiac and cerebrovascular events. Reactions Weekly 1945, 8 (2023). https://doi.org/10.1007/s40278-023-34089-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-023-34089-6